The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population

Journal of Clinical Lipidology

Volumn 10, Issue 2, 2016, Pages 289-298

  Yang, Moon Hee ^a   Sung, Jidong ^a   Gwak, Geum Youn ^a  

^a Samsung Medical Center   (South Korea)

Author keywords

Apolipoprotein A1; Apolipoprotein B; Apolipoprotein B A1 ratio; Nonalcoholic fatty liver disease

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANALYTICAL PARAMETERS; APOLIPOPROTEIN B TO TO APOLIPOPROTEIN A1 RATIO; ARTICLE; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; KOREA; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; COMPLICATION; METABOLIC SYNDROME X; MIDDLE AGED; SOUTH KOREA;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OVERWEIGHT; REPUBLIC OF KOREA;

EID: 84952900660     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2015.11.017     Document Type: Article

References (42)

1. B.W. Smith, and L.A. Adams Non-alcoholic fatty liver disease Crit Rev Clin Lab Sci 48 2011 97 113
2. S. Chitturi, V.W. Wong, and G. Farrell Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground J Gastroenterol Hepatol 26 Suppl 1 2011 163 172
3. M. Lazo, R. Hernaez, M.S. Eberhardt, and et al. Prevalence of nonalcoholic Fatty liver disease in the United States: the third national health and nutrition examination survey, 1988-1994 Am J Epidemiol 178 2013 38 45
4. J.P. Ong, and Z.M. Younossi Epidemiology and natural history of NAFLD and NASH Clin Liver Dis 11 2007 1 16 vii
5. K. Qureshi, and G.A. Abrams Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease World J Gastroenterol 13 2007 3540 3553
6. M.H. Ahmed, S. Barakat, and A.O. Almobarak Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? J Obes 2012 2012 483135
7. M. Machado, and H. Cortez-Pinto Non-alcoholic fatty liver disease and insulin resistance Eur J Gastroenterol Hepatol 17 2005 823 826
8. E. Vanni, E. Bugianesi, A. Kotronen, S. De Minicis, H. Yki-Jarvinen, and G. Svegliati-Baroni From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 42 2010 320 330
9. M.R. Pagadala, and A.J. McCullough Non-alcoholic fatty liver disease and obesity: not all about body mass index Am J Gastroenterol 107 2012 1859 1861
10. D.N. Amarapurkar, E. Hashimoto, L.A. Lesmana, J.D. Sollano, P.J. Chen, and K.L. Goh How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol 22 2007 788 793
11. K. Das, K. Das, P.S. Mukherjee, and et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease Hepatology 51 2010 1593 1602
12. J.G. Fan, T. Saibara, S. Chitturi, B.I. Kim, J.J. Sung, and A. Chutaputti What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? J Gastroenterol Hepatol 22 2007 794 800
13. G. Targher, F. Marra, and G. Marchesini Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 51 2008 1947 1953
14. W. Nseir, A. Shalata, A. Marmor, and N. Assy Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease Dig Dis Sci 56 2011 3439 3449
15. K.C. Sung, M.C. Ryan, and A.M. Wilson The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects Atherosclerosis 203 2009 581 586
16. G. Walldius, and I. Jungner The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - A review of the evidence J Intern Med 259 2006 493 519
17. J.H. Ryoo, and S.K. Park Association of apolipoprotein B and incidence of metabolic syndrome in Korean men: a 5-years' follow-up study Atherosclerosis 226 2013 496 501
18. C.H. Jung, J.Y. Hwang, J.H. Yu, and et al. The value of apolipoprotein B/A1 ratio in the diagnosis of metabolic syndrome in a Korean population Clin Endocrinol (Oxf) 77 2012 699 706
19. M. Andrikoula, and I.F. McDowell The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment Diabetes Obes Metab 10 2008 271 278
20. B. Lamarche, S. Moorjani, P.J. Lupien, and et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study Circulation 94 1996 273 278
21. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies Lancet 363 2004 157 163
22. R.A. McPherson, and M.R. Pincs Henry's clinical diagnosis and management by laboratory methods 22th ed 2011 Elsevier Saunders Philadelphia 211 308
23. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
24. S. Dasarathy, J. Dasarathy, A. Khiyami, R. Joseph, R. Lopez, and A.J. McCullough Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study J Hepatol 51 2009 1061 1067
25. R. Hernaez, M. Lazo, S. Bonekamp, and et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis Hepatology 54 2011 1082 1090
26. S.M. Grundy, J.I. Cleeman, S.R. Daniels, and et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2005 2735 2752
27. S.Y. Lee, H.S. Park, D.J. Kim, and et al. Appropriate waist circumference cutoff points for central obesity in Korean adults Diabetes Res Clin Pract 75 2007 72 80
28. R. Chhabra, J.H. O'Keefe, H. Patil, and et al. Association of coronary artery calcification with hepatic steatosis in asymptomatic individuals Mayo Clin Proc 88 2013 1259 1265
29. D. Kim, S.Y. Choi, E.H. Park, and et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification Hepatology 56 2012 605 613
30. M. Boddi, R. Tarquini, M. Chiostri, and et al. Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes Eur J Clin Invest 43 2013 429 438
31. G. Targher, L. Bertolini, R. Padovani, and et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients Diabetes Care 30 2007 1212 1218
32. C.H. Chen, C.K. Nien, C.C. Yang, and Y.H. Yeh Association between nonalcoholic fatty liver disease and coronary artery calcification Dig Dis Sci 55 2010 1752 1760
33. S.Y. Choi, D. Kim, H.J. Kim, and et al. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans Am J Gastroenterol 104 2009 1953 1960
34. V.W. Wong, G.L. Wong, G.W. Yip, and et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease Gut 60 2011 1721 1727
35. L.B. VanWagner, H. Ning, C.E. Lewis, and et al. Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: The Coronary Artery Risk Development in Young Adults Study Atherosclerosis 235 2014 599 605
36. Y.G. Choe, W. Jin, Y.K. Cho, and et al. Apolipoprotein B/AI ratio is independently associated with non-alcoholic fatty liver disease in nondiabetic subjects J Gastroenterol Hepatol 28 2013 678 683
37. E. Bugianesi, A.J. McCullough, and G. Marchesini Insulin resistance: a metabolic pathway to chronic liver disease Hepatology 42 2005 987 1000
38. E. Ferrannini, and P. Iozzo Is insulin resistance atherogenic? A review of the evidence Atheroscler Suppl 7 2006 5 10
39. M. Gaggini, M. Morelli, E. Buzzigoli, R.A. DeFronzo, E. Bugianesi, and A. Gastaldelli Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease Nutrients 5 2013 1544 1560
40. C. Pagano, G. Soardo, W. Esposito, and et al. Plasma adiponectin is decreased in nonalcoholic fatty liver disease Eur J Endocrinol 152 2005 113 118
41. T. Mito, S. Miura, A. Iwata, and et al. Determination of the cut-off plasma adiponectin level associated with a lower risk of restenosis in patients with stable angina Coron Artery Dis 22 2011 451 457
42. K. Kang, J. Sung, and C.Y. Kim High risk groups in health behavior defined by clustering of smoking, alcohol, and exercise habits: National Heath and Nutrition Examination Survey J Prev Med Public Health 43 2010 73 83